<p>瑞银资产管理（UBS AM）作为瑞银资产管理美洲有限公司（UBS ASSET MANAGEMENT AMERICAS LLC）的一项独立业务单位，在最近向证券交易委员会提交的文件中显示，其在赛默飞世尔科技公司（Thermo Fisher Scientific Inc.，NYSE:TMO - 免费报告）的股份在第四季度增加了 0.6%。该基金在本季度购买了额外的 13,728 股后，持有 2,428,731 股该医疗研究公司的股票。根据其最近向证券交易委员会提交的文件，瑞银资产管理大约拥有赛默飞世尔科技 0.65% 的股份，价值为 14.07328 亿美元。</p>
<ul>
<li>市场正在抛售一切，但这 5 只股票却没有崩溃</li>
</ul>
<p>其他一些对冲基金和机构投资者最近也增加或减少了在 TMO 的持股。先锋集团（Vanguard Group Inc.）在第四季度将其在赛默飞世尔科技的持股提高了 0.9%。先锋集团目前拥有 34,133,702 股该医疗研究公司的股票，价值为 197.78774 亿美元，此前在上个季度购买了额外的 288,296 股。资本世界投资者（Capital World Investors）在第四季度将其在赛默飞世尔科技的持股提高了 7.0%。资本世界投资者目前拥有 11,003,814 股该医疗研究公司的股票，价值为 63.76229 亿美元，此前在上个季度购买了额外的 718,669 股。Geode Capital Management LLC 在第四季度将其在赛默飞世尔科技的持股提高了 0.3%。Geode Capital Management LLC 目前拥有 8,196,477 股该医疗研究公司的股票，价值为 47.28129 亿美元，此前在上个季度购买了额外的 26,425 股。富兰克林资源公司（Franklin Resources Inc.）在第四季度将其在赛默飞世尔科技的持股提高了 7.1%。富兰克林资源公司目前拥有 6,346,512 股该医疗研究公司的股票，价值为 36.77486 亿美元，此前在上个季度购买了额外的 420,841 股。最后，挪威银行（Norges Bank）在第四季度购买了赛默飞世尔科技的新股份，价值为 30.72744 亿美元。目前 89.23% 的股票由机构投资者持有。</p>
<h2>赛默飞世尔科技的价格表现</h2>
<p>赛默飞世尔科技（NYSE:TMO）周五开盘价为 468.80 美元。该公司的债务与股本比率为 0.77，流动比率为 1.53，速动比率为 1.15。赛默飞世尔科技的 1 年最低价为 385.46 美元，1 年最高价为 643.99 美元。该公司的市值为 1742.2 亿美元，市盈率为 25.77，市盈增长比率为 2.11，贝塔值为 0.88。该公司的 50 日简单移动平均线为 479.14 美元，200 日简单移动平均线为 527.68 美元。</p>
<ul>
<li>华尔街热爱的医疗保健领域的常被忽视的角落</li>
</ul>
<p>赛默飞世尔科技（NYSE:TMO - 获取免费报告）最近于 4 月 23 日（星期四）发布了季度财报。该医疗研究公司报告本季度每股收益为 5.44 美元，超出市场共识预期的 5.25 美元，超出幅度为 0.19 美元。赛默飞世尔科技的净利润率为 15.15%，股本回报率为 16.86%。该公司本季度的收入为 110.1 亿美元，而市场共识预期为 108.6 亿美元。在去年同期，该公司每股收益为 5.15 美元。该公司本季度的收入同比增长 6.2%。赛默飞世尔科技已将其 2026 财年的指引设定为每股收益 24.640-25.120 美元。研究分析师预计赛默飞世尔科技将在当前财年发布每股收益 24.86 美元。</p>
<h2>赛默飞世尔科技宣布分红</h2>
<p>该公司最近还宣布了一项季度分红，将于 7 月 15 日（星期三）支付。6 月 15 日（星期一）登记在册的股东将获得每股 0.47 美元的分红。该分红的除息日为 6 月 15 日（星期一）。这代表着每年 1.88 美元的分红，收益率为 0.4%。赛默飞世尔科技的派息比率目前为 10.34%。</p>
<h2>内部人士下注</h2>
<ul>
<li>行业轮动：2026 年的 2 个聪明资金动向</li>
</ul>
<p>在其他赛默飞世尔科技的新闻中，首席运营官 Gianluca Pettiti 于 4 月 27 日（星期一）出售了 400 股赛默飞世尔科技的股票。该股票以 462.66 美元的平均价格出售，总交易额为 185,064.00 美元。交易后，首席运营官持有该公司 25,051 股股票，价值为 11,590,095.66 美元。此次交易使其持股减少了 1.57%。该交易已在向证券交易委员会提交的文件中披露，文件可通过 SEC 网站获取。该交易是在预先安排的 10b5-1 交易计划下执行的。0.33% 的股票由公司内部人士持有。</p>
<h2>华尔街分析师的看法</h2>
<p>几位研究分析师最近对 TMO 股票发布了报告。摩根士丹利（Morgan Stanley）重申了 “增持” 评级，并在 4 月 27 日的研究报告中对赛默飞世尔科技的股票设定了 620.00 美元的目标价。Wolfe Research 在 6 月 2 日（星期二）开始对赛默飞世尔科技的股票进行覆盖。他们设定了 “跑赢大盘” 的评级和 535.00 美元的目标价。DZ Bank 在 3 月 27 日（星期五）开始对赛默飞世尔科技的股票进行覆盖。他们设定了 “买入” 评级和 610.00 美元的目标价。Robert W. Baird 将赛默飞世尔科技的股票目标价从 653.00 美元下调至 639.00 美元，并在 4 月 24 日的报告中设定了 “跑赢大盘” 的评级。最后，巴克莱（Barclays）将赛默飞世尔科技的股票目标价从 650.00 美元下调至 625.00 美元，并在 4 月 14 日的报告中设定了 “增持” 的评级。两位投资分析师对该股票给予了强烈买入评级，十八位给予了买入评级，五位对该公司给予了持有评级。根据 MarketBeat 的数据，该股票目前的共识评级为 “适度买入”，共识目标价为 608.95 美元。</p>
<p><strong>查看我们对赛默飞世尔的最新分析</strong></p>
<h2>关于赛默飞世尔</h2>
<p>（免费报告）</p>
<p>赛默飞世尔（Thermo Fisher Scientific）纽约证券交易所代码：TMO，是全球科学仪器、试剂和耗材、软件及服务的提供商，支持研究、临床和工业实验室。该公司提供分析仪器和实验室设备、生命科学试剂和试剂盒、专业诊断以及研究人员、临床医生和制造商使用的广泛耗材。其产品还包括实验室信息管理和数据分析软件，以及帮助客户高效运行复杂工作流程的服务解决方案，如仪器维护、验证和物流。</p>
<p>赛默飞世尔通过多个业务领域运营，广泛涵盖生命科学解决方案、分析仪器、专业诊断、实验室产品和生物制药服务，包括为制药和生物技术公司提供的合同开发和制造服务。</p>
<h2>精选故事</h2>
<ul>
<li>我们更看好的五只股票，胜过赛默飞世尔</li>
<li>SpaceX 敲响开盘钟，打破所有记录</li>
<li>Adobe 股票刚刚变便宜——华尔街是否忽视了这个故事？</li>
<li>3 只股息股票，价格低于 50 美元，支付你等待通货膨胀的费用</li>
<li>127 吉瓦的问题：为什么人工智能需要自己的电力</li>
</ul>
<p><strong>想看看其他对 TMO 感兴趣的对冲基金持有哪些股票？</strong> 访问 HoldingsChannel.com，获取赛默飞世尔公司（NYSE:TMO - 免费报告）的最新 13F 文件和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRNTw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRNTw"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在赛默飞世尔吗？</h2>
<p>在考虑赛默飞世尔之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买……而赛默飞世尔并不在名单上。</p>
<p>虽然赛默飞世尔目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

赛默飞世尔

瑞银集团

<p>瑞银资产管理在第四季度将其在赛默飞世尔（TMO）的持股增加了 0.6%，持有 243 万股，价值 14 亿美元。其他机构投资者，包括先锋集团和资本世界投资者，也提高了他们的持仓。同时，TMO 报告了强劲的第一季度业绩，收益每股 5.44 美元，营收达到 110.1 亿美元，超出预期。公司宣布每季度派发 0.47 美元的股息，首席运营官 Gianluca Pettiti 根据预先安排的计划出售了 400 股</p>

<p>UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 0.6% in the fourth quarter, according to its most recent filing with the Securities &amp; Exchange Commission. The fund owned 2,428,731 shares of the medical research company's stock after buying an additional 13,728 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.65% of Thermo Fisher Scientific worth $1,407,328,000 as of its most recent filing with the Securities &amp; Exchange Commission.</p>
<div class="lb-trans"><p>瑞银资产管理（UBS AM）作为瑞银资产管理美洲有限公司（UBS ASSET MANAGEMENT AMERICAS LLC）的一项独立业务单位，在最近向证券交易委员会提交的文件中显示，其在赛默飞世尔科技公司（Thermo Fisher Scientific Inc.，NYSE:TMO - 免费报告）的股份在第四季度增加了 0.6%。该基金在本季度购买了额外的 13,728 股后，持有 2,428,731 股该医疗研究公司的股票。根据其最近向证券交易委员会提交的文件，瑞银资产管理大约拥有赛默飞世尔科技 0.65% 的股份，价值为 14.07328 亿美元。</p>
</div><ul>
<li>The Market Is Selling Everything, but These 5 Stocks Aren't Breaking Down</li>
</ul>
<div class="lb-trans"><ul>
<li>市场正在抛售一切，但这 5 只股票却没有崩溃</li>
</ul>
</div><p>A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in TMO. Vanguard Group Inc. raised its holdings in Thermo Fisher Scientific by 0.9% in the 4th quarter. Vanguard Group Inc. now owns 34,133,702 shares of the medical research company's stock worth $19,778,774,000 after purchasing an additional 288,296 shares in the last quarter. Capital World Investors raised its holdings in Thermo Fisher Scientific by 7.0% in the 4th quarter. Capital World Investors now owns 11,003,814 shares of the medical research company's stock worth $6,376,229,000 after purchasing an additional 718,669 shares in the last quarter. Geode Capital Management LLC raised its holdings in Thermo Fisher Scientific by 0.3% in the 4th quarter. Geode Capital Management LLC now owns 8,196,477 shares of the medical research company's stock worth $4,728,129,000 after purchasing an additional 26,425 shares in the last quarter. Franklin Resources Inc. raised its holdings in Thermo Fisher Scientific by 7.1% in the 4th quarter. Franklin Resources Inc. now owns 6,346,512 shares of the medical research company's stock worth $3,677,486,000 after purchasing an additional 420,841 shares in the last quarter. Finally, Norges Bank bought a new position in Thermo Fisher Scientific in the 4th quarter worth $3,072,744,000. 89.23% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>其他一些对冲基金和机构投资者最近也增加或减少了在 TMO 的持股。先锋集团（Vanguard Group Inc.）在第四季度将其在赛默飞世尔科技的持股提高了 0.9%。先锋集团目前拥有 34,133,702 股该医疗研究公司的股票，价值为 197.78774 亿美元，此前在上个季度购买了额外的 288,296 股。资本世界投资者（Capital World Investors）在第四季度将其在赛默飞世尔科技的持股提高了 7.0%。资本世界投资者目前拥有 11,003,814 股该医疗研究公司的股票，价值为 63.76229 亿美元，此前在上个季度购买了额外的 718,669 股。Geode Capital Management LLC 在第四季度将其在赛默飞世尔科技的持股提高了 0.3%。Geode Capital Management LLC 目前拥有 8,196,477 股该医疗研究公司的股票，价值为 47.28129 亿美元，此前在上个季度购买了额外的 26,425 股。富兰克林资源公司（Franklin Resources Inc.）在第四季度将其在赛默飞世尔科技的持股提高了 7.1%。富兰克林资源公司目前拥有 6,346,512 股该医疗研究公司的股票，价值为 36.77486 亿美元，此前在上个季度购买了额外的 420,841 股。最后，挪威银行（Norges Bank）在第四季度购买了赛默飞世尔科技的新股份，价值为 30.72744 亿美元。目前 89.23% 的股票由机构投资者持有。</p>
</div><h2>Thermo Fisher Scientific Price Performance</h2>
<div class="lb-trans"><h2>赛默飞世尔科技的价格表现</h2>
</div><p>Shares of NYSE:TMO opened at $468.80 on Friday. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.53 and a quick ratio of 1.15. Thermo Fisher Scientific Inc. has a 1-year low of $385.46 and a 1-year high of $643.99. The company has a market capitalization of $174.22 billion, a P/E ratio of 25.77, a P/E/G ratio of 2.11 and a beta of 0.88. The firm's 50 day simple moving average is $479.14 and its two-hundred day simple moving average is $527.68.</p>
<div class="lb-trans"><p>赛默飞世尔科技（NYSE:TMO）周五开盘价为 468.80 美元。该公司的债务与股本比率为 0.77，流动比率为 1.53，速动比率为 1.15。赛默飞世尔科技的 1 年最低价为 385.46 美元，1 年最高价为 643.99 美元。该公司的市值为 1742.2 亿美元，市盈率为 25.77，市盈增长比率为 2.11，贝塔值为 0.88。该公司的 50 日简单移动平均线为 479.14 美元，200 日简单移动平均线为 527.68 美元。</p>
</div><ul>
<li>The Often-Missed Corner of Healthcare That Wall Street Is Loving</li>
</ul>
<div class="lb-trans"><ul>
<li>华尔街热爱的医疗保健领域的常被忽视的角落</li>
</ul>
</div><p>Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last issued its quarterly earnings results on Thursday, April 23rd. The medical research company reported $5.44 earnings per share for the quarter, beating the consensus estimate of $5.25 by $0.19. Thermo Fisher Scientific had a net margin of 15.15% and a return on equity of 16.86%. The business had revenue of $11.01 billion for the quarter, compared to the consensus estimate of $10.86 billion. During the same quarter in the previous year, the firm earned $5.15 earnings per share. The company's revenue for the quarter was up 6.2% on a year-over-year basis. Thermo Fisher Scientific has set its FY 2026 guidance at 24.640-25.120 EPS. Research analysts expect that Thermo Fisher Scientific Inc. will post 24.86 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>赛默飞世尔科技（NYSE:TMO - 获取免费报告）最近于 4 月 23 日（星期四）发布了季度财报。该医疗研究公司报告本季度每股收益为 5.44 美元，超出市场共识预期的 5.25 美元，超出幅度为 0.19 美元。赛默飞世尔科技的净利润率为 15.15%，股本回报率为 16.86%。该公司本季度的收入为 110.1 亿美元，而市场共识预期为 108.6 亿美元。在去年同期，该公司每股收益为 5.15 美元。该公司本季度的收入同比增长 6.2%。赛默飞世尔科技已将其 2026 财年的指引设定为每股收益 24.640-25.120 美元。研究分析师预计赛默飞世尔科技将在当前财年发布每股收益 24.86 美元。</p>
</div><h2>Thermo Fisher Scientific Announces Dividend</h2>
<div class="lb-trans"><h2>赛默飞世尔科技宣布分红</h2>
</div><p>The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Monday, June 15th will be issued a dividend of $0.47 per share. The ex-dividend date of this dividend is Monday, June 15th. This represents a $1.88 annualized dividend and a yield of 0.4%. Thermo Fisher Scientific's payout ratio is currently 10.34%.</p>
<div class="lb-trans"><p>该公司最近还宣布了一项季度分红，将于 7 月 15 日（星期三）支付。6 月 15 日（星期一）登记在册的股东将获得每股 0.47 美元的分红。该分红的除息日为 6 月 15 日（星期一）。这代表着每年 1.88 美元的分红，收益率为 0.4%。赛默飞世尔科技的派息比率目前为 10.34%。</p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>内部人士下注</h2>
</div><ul>
<li>Sector Rotation: 2 Smart Money Moves for 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>行业轮动：2026 年的 2 个聪明资金动向</li>
</ul>
</div><p>In other Thermo Fisher Scientific news, COO Gianluca Pettiti sold 400 shares of Thermo Fisher Scientific stock in a transaction that occurred on Monday, April 27th. The shares were sold at an average price of $462.66, for a total transaction of $185,064.00. Following the transaction, the chief operating officer owned 25,051 shares of the company's stock, valued at $11,590,095.66. The trade was a 1.57% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.33% of the stock is owned by corporate insiders.</p>
<div class="lb-trans"><p>在其他赛默飞世尔科技的新闻中，首席运营官 Gianluca Pettiti 于 4 月 27 日（星期一）出售了 400 股赛默飞世尔科技的股票。该股票以 462.66 美元的平均价格出售，总交易额为 185,064.00 美元。交易后，首席运营官持有该公司 25,051 股股票，价值为 11,590,095.66 美元。此次交易使其持股减少了 1.57%。该交易已在向证券交易委员会提交的文件中披露，文件可通过 SEC 网站获取。该交易是在预先安排的 10b5-1 交易计划下执行的。0.33% 的股票由公司内部人士持有。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师的看法</h2>
</div><p>Several research analysts recently issued reports on TMO shares. Morgan Stanley reiterated an &#34;overweight&#34; rating and issued a $620.00 price target on shares of Thermo Fisher Scientific in a research note on Monday, April 27th. Wolfe Research started coverage on shares of Thermo Fisher Scientific in a research note on Tuesday, June 2nd. They set an &#34;outperform&#34; rating and a $535.00 price objective for the company. DZ Bank started coverage on shares of Thermo Fisher Scientific in a report on Friday, March 27th. They set a &#34;buy&#34; rating and a $610.00 price target on the stock. Robert W. Baird dropped their price target on shares of Thermo Fisher Scientific from $653.00 to $639.00 and set an &#34;outperform&#34; rating on the stock in a report on Friday, April 24th. Finally, Barclays dropped their price target on shares of Thermo Fisher Scientific from $650.00 to $625.00 and set an &#34;overweight&#34; rating on the stock in a report on Tuesday, April 14th. Two investment analysts have rated the stock with a Strong Buy rating, eighteen have given a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $608.95.</p>
<div class="lb-trans"><p>几位研究分析师最近对 TMO 股票发布了报告。摩根士丹利（Morgan Stanley）重申了 “增持” 评级，并在 4 月 27 日的研究报告中对赛默飞世尔科技的股票设定了 620.00 美元的目标价。Wolfe Research 在 6 月 2 日（星期二）开始对赛默飞世尔科技的股票进行覆盖。他们设定了 “跑赢大盘” 的评级和 535.00 美元的目标价。DZ Bank 在 3 月 27 日（星期五）开始对赛默飞世尔科技的股票进行覆盖。他们设定了 “买入” 评级和 610.00 美元的目标价。Robert W. Baird 将赛默飞世尔科技的股票目标价从 653.00 美元下调至 639.00 美元，并在 4 月 24 日的报告中设定了 “跑赢大盘” 的评级。最后，巴克莱（Barclays）将赛默飞世尔科技的股票目标价从 650.00 美元下调至 625.00 美元，并在 4 月 14 日的报告中设定了 “增持” 的评级。两位投资分析师对该股票给予了强烈买入评级，十八位给予了买入评级，五位对该公司给予了持有评级。根据 MarketBeat 的数据，该股票目前的共识评级为 “适度买入”，共识目标价为 608.95 美元。</p>
</div><p><strong>Check Out Our Latest Analysis on Thermo Fisher Scientific</strong></p>
<div class="lb-trans"><p><strong>查看我们对赛默飞世尔的最新分析</strong></p>
</div><h2>About Thermo Fisher Scientific</h2>
<div class="lb-trans"><h2>关于赛默飞世尔</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Thermo Fisher Scientific NYSE: TMO is a global provider of scientific instrumentation, reagents and consumables, software, and services that support research, clinical, and industrial laboratories. The company supplies analytical instruments and laboratory equipment, life sciences reagents and kits, specialty diagnostics, and a broad range of consumables used by researchers, clinicians, and manufacturers. Its offerings also include laboratory information management and data-analysis software, as well as service solutions such as instrument maintenance, validation, and logistics that help customers run complex workflows efficiently.</p>
<div class="lb-trans"><p>赛默飞世尔（Thermo Fisher Scientific）纽约证券交易所代码：TMO，是全球科学仪器、试剂和耗材、软件及服务的提供商，支持研究、临床和工业实验室。该公司提供分析仪器和实验室设备、生命科学试剂和试剂盒、专业诊断以及研究人员、临床医生和制造商使用的广泛耗材。其产品还包括实验室信息管理和数据分析软件，以及帮助客户高效运行复杂工作流程的服务解决方案，如仪器维护、验证和物流。</p>
</div><p>Thermo Fisher operates through multiple business areas that broadly cover life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services, including contract development and manufacturing for pharmaceutical and biotechnology companies.</p>
<div class="lb-trans"><p>赛默飞世尔通过多个业务领域运营，广泛涵盖生命科学解决方案、分析仪器、专业诊断、实验室产品和生物制药服务，包括为制药和生物技术公司提供的合同开发和制造服务。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Thermo Fisher Scientific</li>
<li>SpaceX Rings the Bell and Shatters Every Record</li>
<li>Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?</li>
<li>3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation</li>
<li>The 127-Gigawatt Problem: Why AI Needs Its Own Power</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过赛默飞世尔</li>
<li>SpaceX 敲响开盘钟，打破所有记录</li>
<li>Adobe 股票刚刚变便宜——华尔街是否忽视了这个故事？</li>
<li>3 只股息股票，价格低于 50 美元，支付你等待通货膨胀的费用</li>
<li>127 吉瓦的问题：为什么人工智能需要自己的电力</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding TMO?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对 TMO 感兴趣的对冲基金持有哪些股票？</strong> 访问 HoldingsChannel.com，获取赛默飞世尔公司（NYSE:TMO - 免费报告）的最新 13F 文件和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRNTw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=TMO"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Thermo Fisher Scientific Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在赛默飞世尔吗？</h2>
</div><p>Before you consider Thermo Fisher Scientific, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑赛默飞世尔之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Thermo Fisher Scientific wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买……而赛默飞世尔并不在名单上。</p>
</div><p>While Thermo Fisher Scientific currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然赛默飞世尔目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stake in Thermo Fisher Scientific Inc. $TMO

Market Beat

富兰克林资源

摩根士丹利

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

瑞银资产管理美洲有限责任公司（UBS ASSET MANAGEMENT AMERICAS LLC）旗下的独立业务单元 UBS AM 增加了在赛默飞世尔科技公司（Thermo Fisher Scientific Inc.）的持股比例